Company Profile

Smart Quotes

DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs

BSE6103.40142.3 (+2.39 %)

PREV CLOSE ( ) 5961.10

OPEN PRICE ( ) 5988.90

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 4742

TODAY'S LOW / HIGH ( )5978.00 6140.00

52 WK LOW / HIGH ( )4617.1 7077.7

NSE6100.50139.5 (+2.34 %)

PREV CLOSE( ) 5961.00

OPEN PRICE ( ) 5971.00

BID PRICE (QTY) 6100.50 (187)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 394932

TODAY'S LOW / HIGH( ) 5970.00 6150.00

52 WK LOW / HIGH ( )4615.55 7071.5

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 12-10 1990

Management Info

Ramesh BV Nimmagadda - Chairman Murali K Divi - Managing Director

Registered Office

Address 1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli,
Hyderabad,
Telangana-500032

Phone 040 66966300 / 400

Email mail@divislabs.com

Website www.divislabs.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

12Aug Divi's Laboratories informs about tran
Divi's Laboratories has submitted the transcript of the earnings confere..

07Aug Divi’s Laboratories reports 27% rise i
Divi’s Laboratories has reported result for first quarter ended June 30,..

07Aug Divis Laboratories informs about press
Divis Laboratories has informed that it enclosed copies of the newspaper..

26Jul Divis Laboratories informs about board
Divis Laboratories has informed that the meeting of the Board of Directo..

15Jul Divi’s Laboratories informs about cer
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Reg..

Financials

in Millions

	QTR Jun 25	ANNUAL 25
Net Profit	5570	22090
Gross Profit	7470	29290
Operating Profit	8620	33310
Net Sales	23570	91980

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE) 32986.65 (1.99%)	M.Cap ( in Cr)70094.33
Alkem Laboratories (BSE) 5390.90 (4.66%)	M.Cap ( in Cr)64456.30
Glaxosmithkline Phar (BSE) 2773.70 (7.13%)	M.Cap ( in Cr)46988.15
Windlas Biotech (BSE) 1056.80 (10.50%)	M.Cap ( in Cr)2214.98
Caplin Point Lab (BSE) 2160.20 (3.07%)	M.Cap ( in Cr)16420.05

Shareholding Pattern

	PROMOTERS	51.89%
	MUTUAL FUNDS/UTI	13.31%
	NON-INSTITUTION	9.32%
	FI/BANKS/INSURANCE	5.13%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
ICICI Pru Nifty Pharma Index Fund-Reg(G)	10.94
Nippon India Nifty Pharma ETF	10.92
HDFC Pharma and Healthcare Fund-Reg(G)	10.06
Quant Healthcare Fund-Reg(G)	9.99
ITI Pharma & Healthcare Fund-Reg(G)	9.03
Aditya Birla SL Nifty Healthcare ETF	8.96
ICICI Pru Nifty Healthcare ETF	8.96